The estimated Net Worth of Bluebird (Cayman) Ltd Softb... is at least $1.47 milliard dollars as of 4 June 2020. Bluebird Softb owns over 8,912,500 units of Guardant Health Inc stock worth over $349,124,065 and over the last 5 years Bluebird sold GH stock worth over $1,118,463,500.
Bluebird has made over 2 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Bluebird sold 8,912,500 units of GH stock worth $741,163,500 on 4 June 2020.
The largest trade Bluebird's ever made was selling 8,912,500 units of Guardant Health Inc stock on 4 June 2020 worth over $741,163,500. On average, Bluebird trades about 6,906,250 units every 134 days since 2019. As of 4 June 2020 Bluebird still owns at least 14,037,960 units of Guardant Health Inc stock.
You can see the complete history of Bluebird Softb stock trades at the bottom of the page.
Over the last 6 years, insiders at Guardant Health Inc have traded over $2,653,630,540 worth of Guardant Health Inc stock and bought 2,438,210 units worth $45,173,576 . The most active insiders traders include Bluebird (Cayman) Ltd Softb..., Bluebird (Cayman) Ltd Svf E... et Helmy Eltoukhy. On average, Guardant Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of $2,415,822. The most recent stock trade was executed by Kumud Kalia on 9 September 2024, trading 6,545 units of GH stock currently worth $162,774.
we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.
Guardant Health Inc executives and other stock owners filed with the SEC include: